2020-12-14,   《HKEx》- 09939 KINTOR PHARMA-B - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 
2020-12-12,"   《HKEx》- 09939 KINTOR PHARMA-B - VOLUNTARY ANNOUNCEMENT
COMPLETION OF PATIENTS ENROLMENT FOR
PYRILUTAMIDE (KX-826)''S PHASE II
CLINICAL TRIAL FOR INDICATION OF
ANDROGENETIC ALOPECIA IN THE PRC "
2020-11-21,   《HKEx》- 09939 KINTOR PHARMA-B - LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS 
2020-09-18, KINTOR PHARMA-B Soars 12% on Positive Covid Clinical Results of Proxalutamide 
